PDL Biopharma Public
PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities. Intellectual Property Patents The company has been issued patents in the United States and elsewhere, covering the humanization of antibodies, which are referred to as its Queen et al. patents.The company was founded as a Delaware corporation in 1986 under the name Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006.
Industry:
PharmTech
Investment Stage:
N/A
Investor Type:
N/A
Headquarters:
Incline Village, Nevada, United States
Technology:
COVID-19 Investors
Funding Status:
IPO
Number Of Exists:
5
Founded Date:
1986-01-01
Employee Number:
251-500